Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|August 24, 2000
A molecular model for DNA cross-linking by the antitumor agent azinomycin BS Alcaro, R S Coleman
SAR and QSAR in Environmental Research|February 5, 2004
Theoretical comparison between structural and dynamical features of Dolastatins 11 and 12 antineoplastic depsipeptidesS Alcaro, T Marino, F Ortuso, et al.
Journal of Computational Chemistry|February 7, 2007
"Quasi flexible" automatic docking processing for studying stereoselective recognition mechanisms, part 2: Prediction of DeltaDeltaG of complexation and 1H-NMR NOE correlationS Alcaro, F Gasparrini, O Incani, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Conformational search of antisense nucleotidesS Alcaro, A Tafi, F Ortuso, et al.
Bioorganic & Medicinal Chemistry|March 19, 2004
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agentsS Alcaro, A Arena, S Neri, et al.
SAR and QSAR in Environmental Research|July 27, 2007
Molecular modelling and enzymatic studies of acetylcholinesterase and butyrylcholinesterase recognition with paraquat and related compoundsS Alcaro, R Arcone, I Vecchio, et al.
Journal of Biotechnology|February 27, 2007
An approach to address Candida rugosa lipase regioselectivity in the acylation reactions of trytilated glucosidesC Palocci, M Falconi, S Alcaro, et al.
Antimicrobial Agents and Chemotherapy|March 5, 2014
Hepatitis C virus genetic variability and the presence of NS5B resistance-associated mutations as natural polymorphisms in selected genotypes could affect the response to NS5B inhibitorsV C Di Maio, V Cento, C Mirabelli, et al.
European Journal of Medicinal Chemistry|August 13, 2010
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidaseE Maccioni, S Alcaro, F Orallo, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modellingM G Vigorita, R Ottanà, F Monforte, et al.
Pageof 2